Your browser doesn't support javascript.
loading
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial.
Dakin, Helen A; Wordsworth, Sarah; Rogers, Chris A; Abangma, Giselle; Raftery, James; Harding, Simon P; Lotery, Andrew J; Downes, Susan M; Chakravarthy, Usha; Reeves, Barnaby C.
Afiliação
  • Dakin HA; Nuffield Department of Population Health, Health Economics Research Centre, University of Oxford, Oxford, UK.
  • Wordsworth S; Nuffield Department of Population Health, Health Economics Research Centre, University of Oxford, Oxford, UK.
  • Rogers CA; Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK.
  • Abangma G; Swiss Re Services Ltd, Research and Development, London, UK.
  • Raftery J; Primary Care & Population Sciences, University of Southampton, Southampton, UK.
  • Harding SP; Department of Eye and Vision Science, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.
  • Lotery AJ; Academic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Downes SM; Oxford Eye Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
  • Chakravarthy U; Centre for Experimental Medicine, The Queen's University of Belfast, Belfast, UK.
  • Reeves BC; Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, UK.
BMJ Open ; 4(7): e005094, 2014 Jul 29.
Article em En | MEDLINE | ID: mdl-25079928
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Custos de Cuidados de Saúde / Inibidores da Angiogênese / Anticorpos Monoclonais Humanizados / Degeneração Macular Tipo de estudo: Clinical_trials / Diagnostic_studies / Health_economic_evaluation Aspecto: Patient_preference Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMJ Open Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Custos de Cuidados de Saúde / Inibidores da Angiogênese / Anticorpos Monoclonais Humanizados / Degeneração Macular Tipo de estudo: Clinical_trials / Diagnostic_studies / Health_economic_evaluation Aspecto: Patient_preference Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMJ Open Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Reino Unido